
See jobs Follow View all 57 employees About us DreamView is an InfiniteWorld. ZOLL is a registered trademark of ZOLL Medical Corporation in the United States and/or other countries. DreamView Media Production San Francisco, California 1,320 followers DreamView is an InfiniteWorld Technology Solution. in the United States and/or other countries. Respicardia and remedē are registered trademarks of ZOLL Respicardia, Inc. The remedē ® System model 1001 has received CE Mark approval.Ĭopyright © 2021 ZOLL Medical Corporation. For further information, please visit, call +1-95 or email remedē ® System, remedē ® EL System, and remedē ® EL-X System have received FDA approval. If you and your doctor decide to remove the system, another surgery will be required.īe sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the remedē System.

There are additional risks associated with removing your system. The remedē system may not work for everyone. The majority of these events are resolved either on their own or by adjusting the therapy settings.

Once the therapy is turned on, some patients may experience discomfort from stimulation and/or from the presence of the device. The remedē System may be used if you have another stimulation device such as a heart pacemaker or defibrillator special testing will be needed to ensure the devices are not interacting.Īs with any surgically implanted device, there are risks related to the surgical procedure itself which may include, but are not limited to, pain, swelling, and infection. You will not be able to have an MRI or diathermy (special heat therapies) if you have the remedē system implanted. Your doctor will need to evaluate your condition to determine if the remedē system is right for you. We are looking for candidates to join Team Super7 Who we are: Founded in San Francisco in 2001, Super7 is a premier pop-culture collectibles company based in San Francisco, CA.

The remedē ® system is indicated for moderate to severe Central Sleep Apnea in adult patients. × For Patients Important Safety Information
